Home

Kimberly-Clark (KMB)

105.18
+1.42 (1.37%)
NASDAQ · Last Trade: Nov 22nd, 11:20 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
3 Undervalued Dividend Stocks Investors Can Buy Now Before It's Too Latefool.com
The risk appetite among investors is decreasing as the stock market wavers.
Via The Motley Fool · November 21, 2025
Kimberly-Clark's Steadfast Dividend Reflects Resilience Amidst Evolving Consumer Landscape
Irving, Texas – November 20, 2025 – Kimberly-Clark Corporation (NYSE: KMB), a global titan in the consumer goods arena, has once again underscored its unwavering commitment to shareholder returns by declaring a quarterly dividend of $1.26 per share. This latest declaration, consistent with previous payouts throughout the year, signals the company's
Via MarketMinute · November 20, 2025
Don't Give Up on Dividend Stocks. 5 Dividend Kings Down Between 5% and 33% to Buy in Novemberfool.com
Investing in equal parts of these five dividend stocks produces an average yield of 3.9%.
Via The Motley Fool · November 19, 2025
More Pain Ahead For Kenvue Stock? Court Signals Tylenol Autism Cases May Return Amid Retail Bearishnessstocktwits.com
Via Stocktwits · November 18, 2025
3 Value Stocks We Steer Clear Of
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Via StockStory · November 17, 2025
Consumer Brands Shake Things Up...With Mergersfool.com
2025 has been quite the year for consumer brands, but not in a good way. The industry has underperformed for the past three years and many of the world's largest consumer brand companies are resorting to mergers & acquisitions, asset sales, and spin-offs to rejuvenate their prospects.
Via The Motley Fool · November 17, 2025
Court Rejects Bid To Block Kenvue's $398 Million Shareholder Payout In Tylenol Safety Disputebenzinga.com
Texas judge rejects bid to block Kenvue's $398 million dividend and declines to restrict Tylenol marketing as the company faces a lawsuit over pregnancy safety claims.
Via Benzinga · November 17, 2025
Kimberly-Clark, Thermo Fisher Scientific, Berkshire Hathaway And An Industrial Stock On CNBC's 'Final Trades'benzinga.com
Kimberly-Clark is still "oversold after the Kenvue announcement," Jenny Van Leeuwen Harrington says, citing its 5% dividend yield.
Via Benzinga · November 14, 2025
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Avoid
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · November 11, 2025
Jim Cramer Feels These 4 Consumer Packaged Goods Stocks Are 'Undervalued' And Offer 'Too Much Opportunity To Pass Up'stocktwits.com
Cramer also believes the broader sector could be gearing up for a wave of mergers and acquisitions.
Via Stocktwits · November 11, 2025